Dave Williamson
XMFGreenwave4
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Recent Articles by Dave Williamson

Apr 7, 2017
by Dave Williamson
What's Going On At Gilead

Apr 7, 2017
by Dave Williamson
1 Stock the Shorts are Wrong About

Apr 7, 2017
by Dave Williamson
This Popular Biotech Could Be in Trouble

Apr 7, 2017
by Dave Williamson
1 Biotech Back From the Dead

Apr 7, 2017
by Dave Williamson
Time to Go Overweight on Obesity-Drug Makers?

Apr 7, 2017
by Dave Williamson
Big Failure for Big Pharma

Apr 7, 2017
by Dave Williamson
Down 35%, Mannkind No Bargain

Apr 7, 2017
by Dave Williamson
Does This Hostile Takeover Make Sense?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.